LIVN on Nasdaq

LivaNova PLC

British electromedical and electrotherapeutic apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with CONMED Corporation, Integer or TransMedics Group, Inc., or pick any stock.

  • TickerLIVN on Nasdaq1
  • IndustryElectromedical & Electrotherapeutic Apparatus1
  • HeadquartersX01
  • Incorporated inUnited Kingdom2
  • Business address5220 Valiant Court, Gloucester Business Park, Gloucester2
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

LivaNova identifies operating segments based on how it manages, evaluates, and internally reports its business activities to allocate resources, develop and execute its strategy, and assess performance. LivaNova has two reportable segments: Cardiopulmonary and Neuromodulation. “Other” includes non-allocated corporate expenses and the non-cannula results of the Company’s former ACS segment, which was wound down during 2024.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

67.7%Gross margin4
14.4%Operating margin4
-17.5%Net margin4
10.7%Revenue growth, 20254
-20.2%Return on equity4
0.29×Debt to equity4
$173.3MFree cash flow4

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Cardiopulmonary brought in 57% of the revenue LivaNova PLC broke down this way in fiscal 2025.

  1. Cardiopulmonary$785.4M457%up 15% from 2024
  2. Neuromodulation$592.8M443%up 7% from 2024
Business segments by year
Business segments202320242025
Cardiopulmonary$604.1M$683.5M$785.4M
Neuromodulation$519.7M$554.2M$592.8M

Regions

United States brought in 51% of the revenue LivaNova PLC broke down this way in fiscal 2025.

  1. United States$739.6M451%up 6% from 2024
  2. Locations Excluding The United States And Europe$379.3M426%up 12% from 2024
  3. Europe$269.2M419%up 22% from 2024
  4. United Kingdom$55.9M44%up 14% from 2024
Regions by year
Regions202320242025
United States$635.0M$695.1M$739.6M
Locations Excluding The United States And Europe$303.7M$338.3M$379.3M
Europe$214.8M$220.0M$269.2M
United Kingdom$41.5M$48.9M$55.9M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue32¢$448.2M
  • Research and development13¢$185.8M
  • Selling, general and admin40¢$548.8M
  • Other costs13¢$183.7M
  • Income tax2¢$21.6M

Out of $1.4B in revenue.4 The company lost money this year.

Where each dollar of operating cash went, fiscal 2025

  • Capital spending32¢$81.0M
  • Kept or used elsewhere68¢$173.3M

Out of $254.3M of cash from operations.4

Financial statements

Revenue56784$1.4B in 2025+28% since 2019
0$500.0M$1.0B$1.5B2019: $1.1B$1.1B20192020: $934.2M$934.2M2020−14%2021: $1.0B$1.0B2021+11%2022: $1.0B$1.0B2022−1%2023: $1.2B$1.2B2023+13%2024: $1.3B$1.3B2024+9%2025: $1.4B$1.4B2025+11%
Gross profit56784$939.9M in 2025+30% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $723.8M$723.8M20192020: $594.8M$594.8M2020−18%2021: $706.0M$706.0M2021+19%2022: $707.2M$707.2M2022+0%2023: $755.8M$755.8M2023+7%2024: $853.5M$853.5M2024+13%2025: $939.9M$939.9M2025+10%
Operating income56784$199.4M in 2025
-$400.0M-$200.0M0$200.0M2019: -$171.6M-$171.6M20192020: -$273.9M-$273.9M2020+60%2021: -$784.0K-$784.0K2021−100%2022: -$76.8M-$76.8M2022+9690%2023: -$68.5M-$68.5M2023−11%2024: $129.1M$129.1M20242025: $199.4M$199.4M2025+55%
Net income56784-$242.5M in 2025+54% since 2019
-$400.0M-$200.0M0$200.0M2019: -$157.6M-$157.6M20192020: -$348.8M-$348.8M2020+121%2021: -$135.8M-$135.8M2021−61%2022: -$86.2M-$86.2M2022−36%2023: $17.5M$17.5M20232024: $63.2M$63.2M2024+260%2025: -$242.5M-$242.5M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.4

Period ending2025-12-312024-12-312023-12-31
Net revenue$1.4B$1.3B$1.2B
Cost of sales$448.2M$400.0M$397.7M
Gross profit$939.9M$853.5M$755.8M
Selling, general, and administrative$548.8M$508.9M$502.7M
Research and development$185.8M$182.5M$193.8M
Impairment of long-lived assets$0$0$90.0M
Other operating expense$5.9M$33.0M$37.8M
Operating income (loss)$199.4M$129.1M-$68.5M
SNIA environmental liability expense-$365.6M$0$0
Interest expense-$49.3M-$63.1M-$58.9M
Loss on debt extinguishment-$2.7M-$25.5M$0
Foreign exchange and other income/(expense)-$2.7M$47.8M$46.1M
(Loss) income before income tax-$220.8M$88.3M-$81.2M
Income tax expense (benefit)$21.6M$25.1M-$98.9M
Loss from equity method investments-$51.0K-$18.0K-$104.0K
Net (loss) income-$242.5M$63.2M$17.5M
Basic (loss) income per share (in dollars per share)-$4.45$1.17$0.33
Diluted (loss) income per share (in dollars per share)-$4.45$1.16$0.32
Shares used in computing basic (loss) income per share (in shares)54.5M shares54.2M shares53.9M shares
Shares used in computing diluted (loss) income per share (in shares)54.5M shares54.6M shares54.2M shares

Compare LivaNova PLC with another company

Leadership

Who has led LivaNova PLC, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Andre Michel Ballester2015–2017
  2. Damien McDonald2016–2023
  3. William A. Kozy2023–2024
  4. Vladimir Makatsaria2024–now

Chair

  1. William A. Kozy2023–2024

President

  1. Michel Darnaud2015–2016
  2. Rohan Hoare2015
  3. Robert Jason Richey2016
  4. Jacques Gutedel2016
  5. Roy Khoury2020–2021
  6. Marco Dolci2022–2023
  7. Stephanie Bolton2024
  8. Franco Poletti2024–2026
  9. Stefano Folli2026–now

Chief financial officer

  1. Vivid Sehgal2015–2017
  2. Thad Allen Huston2017–2020
  3. Alex Shvartsburg2020–now

Chief operating officer

  1. Damien McDonald2016
20202025
Board members and other officers (35)

Former names

  • Sand Holdco PlcApr 20, 2015 to Jun 12, 20152

Timeline

  1. Mar 4, 2024New chief executive Vladimir Makatsaria becomes CEO12
  2. Dec 19, 2023New chief executive William A. Kozy becomes CEO13
  3. Nov 8, 2016New chief executive Damien McDonald becomes CEO14
  4. Oct 22, 2015New chief executive Andre Michel Ballester becomes CEO15

Filings

322 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 60 major events, 162 insider forms, 19 large holders, 61 other. The latest 20:

  1. Sep 16, 20264 EDGAR
  2. Sep 14, 20264 EDGAR
  3. Sep 10, 2026144 EDGAR
  4. Sep 8, 20264 EDGAR
  5. Sep 4, 2026144 EDGAR
  6. Sep 2, 2026144 EDGAR
  7. Sep 2, 20264 EDGAR
  8. Sep 2, 20263 EDGAR
  9. Aug 31, 2026144 EDGAR
  10. Aug 13, 20264 EDGAR
  11. Aug 11, 2026144 EDGAR
  12. Aug 6, 2026SCHEDULE 13G EDGAR
  13. Aug 5, 2026IRANNOTICE EDGAR
  14. Aug 5, 202610-Q EDGAR
  15. Aug 5, 20263 EDGAR
  16. Aug 5, 20268-K EDGAR
  17. Jun 17, 20264 EDGAR
  18. Jun 17, 20264 EDGAR
  19. Jun 17, 20264 EDGAR
  20. Jun 17, 20264 EDGAR

The 322 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

25 open-market trades by officers, directors and large owners since October 2021: 1 buys and 24 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 10, 2026Bianchi FrancescoDirectorSale3,500$78.01$273.0KForm 4
Sep 4, 2026Story BrookeDirectorSale2,300$81.42$187.3KForm 4
Aug 31, 2026Bianchi FrancescoDirectorSale1,650$79.72$131.5KForm 4
Aug 11, 2026Tezel AhmetChief Innovation OfficerSale2,675$77.74$208.0KForm 4
Jun 15, 2026Bianchi FrancescoDirectorSale1,200$80.19$96.2KForm 4
May 26, 2026Bianchi FrancescoDirectorSale1,800$75.75$136.3KForm 4
Nov 18, 2025Story BrookeDirectorSale250$53.94$13.5KForm 4
Aug 25, 2025Bianchi FrancescoDirectorSale1,500$56.50$84.8KForm 4
Dec 11, 2024Bianchi FrancescoDirectorSale1,250$50.99$63.7KForm 4
Sep 11, 2024Bianchi FrancescoDirectorSale1,500$46.58$69.9KForm 4
Jun 3, 2024Moore Daniel JeffreyDirectorSale56,623$60.12$3.4MForm 4
Mar 30, 2023McDonald DamienCEOSale2,220$42.55$94.5KForm 4
Dec 15, 2022McDonald DamienCEOSale2,220$54.56$121.1KForm 4
Apr 1, 2022Moore Daniel JeffreyDirectorSale1,000$83.42$83.4KForm 4
Mar 29, 2022McDonald DamienCEOSale2,784$81.50$226.9KForm 4
Mar 2, 2022Moore Daniel JeffreyDirectorSale1,000$80.00$80.0KForm 4
Feb 25, 2022Moore Daniel JeffreyDirectorSale1,000$80.00$80.0KForm 4
Jan 3, 2022Moore Daniel JeffreyDirectorSale1,000$85.93$85.9KForm 4
Dec 13, 2021McDonald DamienCEOSale2,784$81.50$226.9KForm 4
Dec 1, 2021Moore Daniel JeffreyDirectorSale1,000$81.73$81.7KForm 4

All 25 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65